1887

Abstract

Yunnan is considered to be a geographical hotspot for the introduction, mutation and recombination of several viruses in China. However, there are limited data regarding the genotypic profiles of hepatitis B virus (HBV) in this region. In this study, we characterized 206 HBV strains isolated from chronic hepatitis B patients in Yunnan, China. Initial genotyping based on 1.5 kb sequences revealed that genotype C was the most prevalent at 52.4 % (108/206), followed by genotype B at 30.6 % (63/206) and unclassified genotypes at 17.0 % (35/206). To characterize the 35 unclassified strains, 32 complete HBV genomes were amplified and analysed; 17 isolates were classified within a known subgenotype, 8 were classified as B/C recombinants, 1 was classified as a B/I recombinant and 6 constituted a potentially novel C subgenotype that we designated as C17, based on the characteristics of a monophyletic cluster, >4 % genetic distances, no significant evidence of recombination and no epidemiological link among individuals. Thus, multiple subgenotypes – namely B1, B2, B4, C1, C2, C3, C4, C8 and C17 – and two distinct intergenotypic recombinants exist in Yunnan, China, highlighting the complex and diverse distribution pattern of HBV genotypic profiles.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001147
2018-09-25
2019-10-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/jgv.001147.zip/jgv001147.html?itemId=/content/journal/jgv/10.1099/jgv.0.001147&mimeType=html&fmt=ahah

References

  1. Smith JM, Uvin AZ, Macmadu A, Rich JD. Epidemiology and treatment of hepatitis B in prisoners. Curr Hepatol Rep 2017;16: 178– 183 [CrossRef] [PubMed]
    [Google Scholar]
  2. Nosratabadi R, Alavian SM, Zare-Bidaki M, Shahrokhi VM, Arababadi MK. Innate immunity related pathogen recognition receptors and chronic hepatitis B infection. Mol Immunol 2017;90: 64– 73 [CrossRef] [PubMed]
    [Google Scholar]
  3. Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. Hepatology 2017;66: 2066– 2077 [CrossRef] [PubMed]
    [Google Scholar]
  4. Lee SY, Lee SH, Kim JE, Kim H, Kim K et al. Identification of novel A2/C2 inter-genotype recombinants of hepatitis B virus from a korean chronic patient co-infected with both genotype A2 and C2. Int J Mol Sci 2017;18: 737 [CrossRef] [PubMed]
    [Google Scholar]
  5. Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol 2017;31: 249– 255 [CrossRef] [PubMed]
    [Google Scholar]
  6. Ito K, Yoneda M, Sakamoto K, Mizokami M. Virological and clinical characteristics of hepatitis B virus genotype A. J Gastroenterol 2018;53: 18– 26 [CrossRef] [PubMed]
    [Google Scholar]
  7. Hübschen JM, Mbah PO, Forbi JC, Otegbayo JA, Olinger CM et al. Detection of a new subgenotype of hepatitis B virus genotype A in Cameroon but not in neighbouring Nigeria. Clin Microbiol Infect 2011;17: 88– 94 [CrossRef] [PubMed]
    [Google Scholar]
  8. Shi W, Zhu C, Zheng W, Carr MJ, Higgins DG et al. Subgenotype reclassification of genotype B hepatitis B virus. BMC Gastroenterol 2012;12: 116 [CrossRef] [PubMed]
    [Google Scholar]
  9. Mulyanto, Pancawardani P, Depamede SN, Wahyono A, Jirintai S et al. Identification of four novel subgenotypes (C13-C16) and two inter-genotypic recombinants (C12/G and C13/B3) of hepatitis B virus in Papua province, Indonesia. Virus Res 2012;163: 129– 140 [CrossRef] [PubMed]
    [Google Scholar]
  10. Hundie GB, Stalin Raj V, Gebre Michael D, Pas SD, Koopmans MP et al. A novel hepatitis B virus subgenotype D10 circulating in Ethiopia. J Viral Hepat 2017;24: 163– 173 [CrossRef] [PubMed]
    [Google Scholar]
  11. Mojsiejczuk LN, Torres C, Pisano MB, Re V, Campos RH et al. New pieces on genetic diversity and evolutionary history of hepatitis B virus: characterization of the novel subgenotype F6. Infect Genet Evol 2017;47: 140– 142 [CrossRef] [PubMed]
    [Google Scholar]
  12. Shen T, Yan XM, Liu HX, Zhang BX, Li L et al. Genotype I of hepatitis B virus was found in east Xishuangbanna, China and molecular dynamics of HBV/I. J Viral Hepat 2015;22: 37– 45 [CrossRef] [PubMed]
    [Google Scholar]
  13. Araujo NM. Hepatitis B virus intergenotypic recombinants worldwide: an overview. Infect Genet Evol 2015;36: 500– 510 [CrossRef] [PubMed]
    [Google Scholar]
  14. Alonso S, Guerra AR, Carreira L, Ferrer , Gutiérrez ML et al. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?. BMC Gastroenterol 2017;17: 168 [CrossRef] [PubMed]
    [Google Scholar]
  15. Liu J, Fan D. Hepatitis B in China. Lancet 2007;369: 1582– 1583 [CrossRef] [PubMed]
    [Google Scholar]
  16. Chang Y, Choe WH, Sinn DH, Lee JH, Ahn SH et al. Nucleos(t)ide analogue treatment for patients with hepatitis B virus (HBV) e antigen-positive chronic HBV genotype C infection: a nationwide, multicenter, retrospective study. J Infect Dis 2017;216: 1407– 1414 [CrossRef] [PubMed]
    [Google Scholar]
  17. Shen S, Liang X, Hamed K, Tanaka Y, Omagari K et al. Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients. Hepatol Res 2018;48: 134– 143 [CrossRef] [PubMed]
    [Google Scholar]
  18. Li HM, Wang JQ, Wang R, Zhao Q, Li L et al. Hepatitis B virus genotypes and genome characteristics in China. World J Gastroenterol 2015;21: 6684– 6697 [CrossRef] [PubMed]
    [Google Scholar]
  19. Wang B, Feng Y, Li Z, Duan H, Zhao T et al. Distribution and diversity of hepatitis B virus genotypes in Yunnan, China. J Med Virol 2014;86: 1675– 1682 [CrossRef] [PubMed]
    [Google Scholar]
  20. You J, Sriplung H, Chongsuvivatwong V, Geater A, Zhuang L et al. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China. Hepatobiliary Pancreat Dis Int 2008;7: 271– 279 [PubMed]
    [Google Scholar]
  21. Shen YY, Hou W, Yang ZQ, Xiao W. Hepatitis B virus infection and genotype in asymptomatic people from 10 ethnic groups in Yunnan, China. World J Gastroenterol 2015;21: 12586– 12592 [CrossRef] [PubMed]
    [Google Scholar]
  22. Nwe NW, Nakamoto S, Myint MS, Moriyama M, Kanda T et al. Hepatitis B virus genotype C is predominant in Myanmar. Diseases 2017;6: 3
    [Google Scholar]
  23. Huy TT, Ushijima H, Quang VX, Win KM, Luengrojanakul P et al. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol 2004;85: 283– 292 [CrossRef] [PubMed]
    [Google Scholar]
  24. Shi W, Zhang Z, Ling C, Zheng W, Zhu C et al. Hepatitis B virus subgenotyping: history, effects of recombination, misclassifications, and corrections. Infect Genet Evol 2013;16: 355– 361 [CrossRef] [PubMed]
    [Google Scholar]
  25. Pourkarim MR, Amini-Bavil-Olyaee S, Kurbanov F, van Ranst M, Tacke F. Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions. World J Gastroenterol 2014;20: 7152– 7168 [CrossRef] [PubMed]
    [Google Scholar]
  26. Castelhano N, Araujo NM, Arenas M. Heterogeneous recombination among Hepatitis B virus genotypes. Infect Genet Evol 2017;54: 486– 490 [CrossRef] [PubMed]
    [Google Scholar]
  27. Liaw YF. Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat 2002;9: 393– 399 [CrossRef] [PubMed]
    [Google Scholar]
  28. Huy TT, Abe K. Molecular epidemiology of hepatitis B and C virus infections in Asia. Pediatr Int 2004;46: 223– 230 [CrossRef] [PubMed]
    [Google Scholar]
  29. Günther S, Li BC, Miska S, Krüger DH, Meisel H et al. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 1995;69: 5437– 5444 [PubMed]
    [Google Scholar]
  30. Günther S, Sommer G, von Breunig F, Iwanska A, Kalinina T et al. Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 1998;36: 531 [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001147
Loading
/content/journal/jgv/10.1099/jgv.0.001147
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error